The absorption-enhancing action of SNAC is thought to be highly dependent on the specific agent it is enhancing, which means that carefully tailored co-formulation is required rather than co-administration [56]
In addition, they have positive impact on several cardiovascular risk factors such as obesity by promoting weight loss, blood pressure and blood lipid levels
Biliary and gallbladder problems associated with using Ozempic, Wegovy, and Mounjaro include Cholecystitis and Cholelithiasis (gallstones)
It is also consistent with a small clinical trial study of the GLP-1RA drug exenatide, which significantly reduced heavy drinking days and total alcohol intake in patients with obesity 12 and with a register-based study in Demark showing that GLP-1RAs (though semaglutide was not included) compared with dipeptidyl peptidase 4 inhibitors (DPP4) were associated with lower incidence of alcohol-related events in 20092017 13
Additionally, tirzepatide may delay gastric emptying, potentially reducing the absorption of oral medications including oral contraceptives